Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.
Journal of Clinical Investigation.
Times cited: 51
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
JAMA - Journal of the American Medical Association.
Times cited: 519